iRhythm Technologies Further Strengthens its Board of Directors with Two New Independent Director Appointments
06 Junho 2023 - 10:00AM
iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital
health care company focused on creating trusted solutions that
detect, predict, and prevent disease, today announced the
appointment of Mojdeh Poul and Brian Yoor as directors to its Board
effective June 1, 2023.
“On behalf of the entire iRhythm team, I am thrilled to welcome
Mojdeh and Brian to our Board of Directors,” said Quentin
Blackford, iRhythm’s President and CEO. “Both bring extensive
operational experience, strong financial acumen, and public company
leadership across the global healthcare and medical technology
sectors. We believe their proven track record of delivering results
and building sustainable long-term value within healthcare will
further strengthen our Board’s depth of expertise and unique
perspectives as we continue to scale on a global basis.”
With their appointment to the Board of Directors, both Ms. Poul
and Mr. Yoor have also been appointed to serve as members of the
Company’s Audit Committee. These additions expand iRhythm’s Board
to nine directors, eight of whom are independent members.
“Mojdeh is an accomplished, purpose-driven healthcare executive
and is recognized for her experience in accelerating growth through
portfolio transformation and reliably delivering results through
diverse, high-performance leadership teams. Brian is a seasoned
global financial executive and has led multi-national companies
through transformative periods that have led to sustainable
financial strength, business growth and value creation,” said Abhi
Talwalkar, Chairman of the Board of Directors. “Mojdeh and Brian’s
deep industry knowledge and experience will be invaluable in
guiding us to grow our business, efficiently scale our operations
and deliver on the significant growth opportunity ahead.”
About Mojdeh PoulMojdeh Poul is an accomplished
healthcare executive with over thirty years of extensive experience
leading global businesses and operations in large multinational
organizations. Most recently, Ms. Poul served as the Executive Vice
President and Group President of 3M Healthcare Business from April
2019 to June 2022. In this role, she led the global P&L,
strategy, manufacturing and commercial operations, and R&D for
the $8.6B Healthcare Business Group. Ms. Poul joined 3M in April of
2011 and held multiple leadership roles throughout her tenure,
including as Executive Vice President of Safety & Graphics
Business Group, as President of 3M Canada, and as President of two
divisions within the 3M Healthcare Business Group.
Prior to 3M, Ms. Poul held global business leadership roles of
increasing responsibility with leading global medical technology
companies, including Medtronic, ev3, Boston Scientific, and
Teleflex Medical. In these roles, she led formulation and
implementation of market development strategies to drive global
growth and penetration of neuromodulation and emerging
cardiovascular therapies. Deployed strategies included generation
of world class clinical evidence and health economics data,
physician education and referral development programs, and direct
to patient marketing.
Ms. Poul has served on the Board of Stanley Black and Decker
since February of 2021, where she is a member of the Audit and
Talent & Compensation Committees. She holds an MBA from
University of North Carolina at Chapel Hill as well as a Master of
Engineering and Bachelor of Science in Mechanical Engineering from
University of Louisville.
About Brian YoorBrian Yoor is an accomplished
global financial executive with over three decades of leadership
experience in strategy, finance, operations, investor relations,
acquisitions and integrations, and organizational development for
healthcare and start-up companies. Brian spent most of his career
at Abbott, where he concluded his career as Chief Financial
Officer. Prior to that, he held multiple leadership roles including
Division Controller for multiple business units, and Vice President
of investor relations. During his tenure at Abbott, Brian
successfully built and led a performance culture and transformative
change in the areas of capital allocation, enterprise-wide cash
flow, and investor relations.
Mr. Yoor serves as Chairman of the Board for Covira Surgical, a
biotech start-up in the microbiome space, and he previously served
as the founding Chairman and an Operating Partner at Portal
Innovations, a unique venture capital company for early life
science start-ups. He attended the University of Toledo, where he
earned his Bachelor of Business Administration in Accounting.
About iRhythm Technologies, Inc.iRhythm is a
leading digital health care company that creates trusted solutions
that detect, predict, and prevent disease. Combining wearable
biosensors and cloud-based data analytics with powerful proprietary
algorithms, iRhythm distills data from millions of heartbeats into
clinically actionable information. Through a relentless focus on
patient care, iRhythm’s vision is to deliver better data, better
insights, and better health for all.
Forward-Looking StatementsThis news release
contains forward-looking statements within the meaning of Section
27A of the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934 and the Private Securities Litigation Reform
Act of 1995. These statements include statements relating to growth
expectations and personnel matters. Such statements are based on
current assumptions that involve risks and uncertainties that could
cause actual outcomes and results to differ materially. These risks
and uncertainties, many of which are beyond our control, include
risks described in the section entitled “Risk Factors” and
elsewhere in our filings made with the Securities and Exchange
Commission on Forms 10-K and 10-Q. These forward-looking statements
speak only as of the date hereof and should not be unduly relied
upon. iRhythm disclaims any obligation to update these
forward-looking statements.
Investor Relations ContactStephanie
Zhadkevich(919) 452-5430investors@irhythmtech.com
Media ContactSaige Smith (262)
289-7065irhythm@highwirepr.com
iRhythm Technologies (NASDAQ:IRTC)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
iRhythm Technologies (NASDAQ:IRTC)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024